Physician profile
Danielle N Carr
NPI 1285162396
$15,929.64
in general payments reported to CMS, 2019-2025
20 companies · $1,777 in 2025
The $1,777 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $31.40 · 2021: $843 · 2022: $1,646 · 2023: $6,393 · 2024: $5,018 · 2025: $1,777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,317 · Travel and Lodging: $4,928 · Education: $850 · Gift: $75.65 · Entertainment: $17.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,317.45 |
| Travel and Lodging | $4,927.50 |
| Education | $850.00 |
| Gift | $75.65 |
| Entertainment | $17.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,881.81 | 2021-2024 | Axonics, Bulkamid |
| Coloplast Corp | $3,237.23 | 2022-2025 | Altis |
| Boston Scientific Corporation | $2,755.11 | 2021-2025 | Advantage System, Solyx Sis System, Axonics |
| Medtronic, INC. | $1,732.78 | 2021-2025 | Interstim, Altaviva, Nuro |
| Intuitive Surgical, INC. | $1,122.82 | 2024 | |
| Caldera Medical, INC | $862.19 | 2023-2024 | Desara |
| Abbvie INC. | $782.80 | 2020-2025 | Botox |
| Astellas Pharma US INC | $530.20 | 2022-2025 | Veozah, Myrbetriq |
| Allergan, INC. | $272.42 | 2021-2022 | |
| Convatec INC. | $197.13 | 2021-2025 | |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Urovant Sciences INC | $124.88 | 2021-2022 | |
| Pfizer INC. | $91.18 | 2022-2023 | |
| Laborie Medical Technologies Corp. | $52.00 | 2021 | |
| Baxter Healthcare | $49.58 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $32.30 | 2019 | |
| Sumitomo Pharma America, INC. | $22.68 | 2023 | Gemtesa |
| Alexion Pharmaceuticals, INC. | $18.17 | 2019 | |
| Covidien LP | $16.73 | 2020 | |
| Foundation Medicine, INC. | $15.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.